首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer treatment and research

缩写:

ISSN:0927-3042

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引2397
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Samina Akbar,Abdur Rahman,Nazir Ahmad et al. Samina Akbar et al.
Polyunsaturated fatty acids (PUFAs), notably omega-3 (n-3) and omega-6 (n-6), have received much attention owing to their multifaceted effects not only in the management of diverse pathological conditions but also in the maintenance of over...
Mahwish Ali,Syeda Mehpara Farhat,Abdul Haleem Mahwish Ali
Several types of environmental, chemical and metabolic carcinogens exist both exogenously and endogenously. Humans are daily exposed to aforementioned carcinogens through various sources such as through water, air and food or through metabo...
Hanadi Talal Ahmedah,Haneen Adel Basheer,Inas Almazari et al. Hanadi Talal Ahmedah et al.
By the beginning of the year 2021, the estimated number of new cancer cases worldwide was about 19.3 million and there were 10.0 million cancer-related deaths. Cancer is one of the deadliest diseases worldwide that can be attributed to gene...
Csongor György Lengyel,Baker Shalal Habeeb,Sara Cecilia Altuna et al. Csongor György Lengyel et al.
There is a growing global debate over barriers affecting the timely access to innovative anticancer therapies. Access to medicines is often traced back to the issue of costs: however, more commonly, the distance between valuable innovative ...
Dario Trapani,Edoardo Crimini,José Sandoval et al. Dario Trapani et al.
The rapid implementation of precision medicine tools in diagnosing and treating breast cancer (BC) has widened the potential therapeutic options for patients. The applications of gene sequencing, including next-generation gene sequencing (N...
Paola Zagami,Eleonora Nicolò,Chiara Corti et al. Paola Zagami et al.
Cancer and cardiovascular disease are the two major causes of morbidity and mortality in worldwide. Discovering new therapeutic agents for the management of breast cancer (BC) has increased the numbers of cancer survivors but with the risk ...
Emanuela Ferraro,Andrew D Seidman Emanuela Ferraro
Brain metastases (BM) significantly affect the prognosis as well as the quality of life of breast cancer (BC) patients. Although advancements in neurosurgical and radiotherapy techniques improve local control and symptom management, BM rema...
Beatrice Taurelli Salimbeni,Emanuela Ferraro,Luca Boscolo Bielo et al. Beatrice Taurelli Salimbeni et al.
Overexpression of human epidermal growth factor receptor 2 (HER2), a transmembrane tyrosine kinase receptor, has been described in about 15-20% of breast cancer (BC) and is associated with poor outcomes. Trastuzumab is the first anti-HER2 m...
Antonio Marra,Dario Trapani,Emanuela Ferraro et al. Antonio Marra et al.
Hormone receptor-positive (HR+) breast cancer (BC) accounts for approximately 70% of all breast invasive tumors. Endocrine therapy (ET) represents the standard treatment for HR + BC. Most patients, however, eventually develop resistance to ...
Federica Giugliano,Laura Boldrini,Jacopo Uliano et al. Federica Giugliano et al.
The impact of nutritional patterns on the risk of breast cancer (BC) is well investigated in the oncology literature, including the type of diets and caloric intake. While obesity and elevated body mass index are well-reported critical risk...